Concepedia

Keith Levert

KL

1

Publications

44

Citations

1

H-Index

2019

Active since

Affiliations

Hopp Children's Cancer Center Heidelberg(Current)

Keith Levert is an author at Hopp Children's Cancer Center Heidelberg specializing in translational medicine, medicine, and pharmacology.

Top concepts

MedicinePharmacologyChronic Kidney DiseaseTranslational Medicine

Publications per year

2019–2019

1

Publications

1

Phase I clinical evaluation of CNSA-001 (sepiapterin), a novel pharmacological treatment for phenylketonuria and tetrahydrobiopterin deficiencies, in healthy volunteers

Neil Smith, Nicola Longo, Keith Levert et al. · Molecular Genetics and Metabolism · 2019 · 44 citations

Translational Medicine, Healthy Volunteers, Chronic Kidney Disease +4

Rows per page

1–1 of 1